The Provider and Organization in Asthma Guidelines

This study has been completed.
Sponsor:
Collaborator:
Information provided by (Responsible Party):
Michelle Cloutier, University of Connecticut Health Center
ClinicalTrials.gov Identifier:
NCT00345514
First received: June 27, 2006
Last updated: November 8, 2012
Last verified: November 2012
  Purpose

The purpose of this study is to examine the interaction between the personal attributes of clinicians and the organizations in which they work and the effect of interventions on their ability to implement an asthma disease management program. +


Condition Intervention
Asthma
Behavioral: Behavioral Intervention Arm
Behavioral: Organizational Interventions Arm

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Health Services Research
Official Title: The Provider and Organization in Asthma Guidelines

Resource links provided by NLM:


Further study details as provided by University of Connecticut Health Center:

Primary Outcome Measures:
  • Number of Easy Breathing Surveys Distributed [ Time Frame: 4 years ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Organizational Culture [ Time Frame: baseline; 12 months and 36 months after intervention phase ] [ Designated as safety issue: No ]

Enrollment: 36
Study Start Date: September 2002
Study Completion Date: September 2012
Primary Completion Date: September 2012 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
No Intervention: 1
Active Comparator: 2 Behavioral: Behavioral Intervention Arm
The arm emphasized individual provider behavior (interactive CME, feedback at the provider, clinic and program levels, expert modeling, academic detailing and opinion leaders)
Other Name: Provider Intervention Arm
Active Comparator: 3 Behavioral: Organizational Interventions Arm
Leadership, team building, benchmarking at the clinic and program level
Other Name: Organizational Arm

Detailed Description:

Less than 20% of primary care providers adhere to national asthma guidelines. Interventions to improve provider adherence to guidelines have had modest success. We believe that changing provider behavior must be viewed in the context of the provider's environment. We hypothesize that providers who are most successful in implementing and sustaining asthma management programs will have a set of personal attributes, related to asthma, characterized by readiness to change, high self-efficacy, positive outcome expectancies and high outcome value AND will work within organizations that facilitate and support such activities. We propose a two phase study. In Phase 1 (Year 1) survey instrument development and testing and provider meetings to discuss the interventions will occur. Providers in 49 practices/clinics that are using an asthma management program called Easy Breathing, will complete these surveys that will characterize the organization and organizational culture of the clinics/practices and the provider personal attributes surrounding asthma. In Years 2-5, a randomized, controlled study of either a behavioral intervention, an organizational intervention or no intervention (control) will be performed in 36 of these clinics/practices. Clinics/practices in the behavioral arm will receive an intervention consisting of expert modeling, program-, clinic- and provider-specific feedback, and use of opinion leaders and academic detailing. Clinics/practices in the organizational arm will receive an intervention consisting of benchmarking, leadership capability training and team building and incentives/ rewards. The primary outcome variable is the number of Easy Breathing surveys completed by provider and by clinic/unit of time. We have previously shown that enrollment in Easy Breathing (which was adapted directly from the national asthma guidelines) as demonstrated by completion of a survey is a surrogate indicator of inhaled corticosteroid use and is associated with decreased medical services utilization. This study will thus investigate the complex interactions between provider personal attributes and the organization and the effect of targeted interventions on provider performance to implement an asthma disease management program. These data will then be used in future studies to determine how to better tailor interventions in a cost constrained environment.

  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Must have used Easy Breathing Disease Management Program for more than one year.

Exclusion Criteria:

  • None
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00345514

Locations
United States, Connecticut
University of Connecticut Health Center
Farmington, Connecticut, United States, 06030
Sponsors and Collaborators
University of Connecticut Health Center
Investigators
Principal Investigator: Michelle M Cloutier, MD University of Connecticut Health Center
  More Information

No publications provided

Responsible Party: Michelle Cloutier, Professor of Pediatrics, University of Connecticut Health Center
ClinicalTrials.gov Identifier: NCT00345514     History of Changes
Other Study ID Numbers: 5 RO1 HL70785, CCMC 01-111
Study First Received: June 27, 2006
Last Updated: November 8, 2012
Health Authority: United States: Institutional Review Board

Keywords provided by University of Connecticut Health Center:
Children
Self-efficacy
Organization
Process of care

Additional relevant MeSH terms:
Asthma
Bronchial Diseases
Respiratory Tract Diseases
Lung Diseases, Obstructive
Lung Diseases
Respiratory Hypersensitivity
Hypersensitivity, Immediate
Hypersensitivity
Immune System Diseases

ClinicalTrials.gov processed this record on September 18, 2014